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Abstract
Background: Cadmium (Cd) is a ubiquitous and environmentally persistent toxic metal that has been implicated in
neurotoxicity, carcinogenesis and obesity and essential metals including zinc (Zn) and iron (Fe) may alter these
outcomes. However mechanisms underlying these relationships remain limited.
Methods: We examined whether maternal Cd levels during early pregnancy were associated with offspring DNA
methylation at regulatory sequences of genomically imprinted genes and weight at birth, and whether Fe and Zn
altered these associations. Cd, Fe and Zn were measured in maternal blood of 319 women ≤12 weeks gestation.
Offspring umbilical cord blood leukocyte DNA methylation at regulatory differentially methylated regions (DMRs) of
8 imprinted genes was measured using bisulfite pyrosequencing. Regression models were used to examine the
relationships among Cd, Fe, Zn, and DMR methylation and birth weight.
Results: Elevated maternal blood Cd levels were associated with lower birth weight (p = 0.03). Higher
maternal blood Cd levels were also associated with lower offspring methylation at the PEG3 DMR in females
(β = 0.55, se = 0.17, p = 0.05), and at the MEG3 DMR in males (β = 0.72, se = 0.3, p = 0.08), however the latter
association was not statistically significant. Associations between Cd and PEG3 and PLAGL1 DNA methylation
were stronger in infants born to women with low concentrations of Fe (p < 0.05).
Conclusions: Our data suggest the association between pre-natal Cd and offspring DNA methylation at
regulatory sequences of imprinted genes may be sex- and gene-specific. Essential metals such as Zn may
mitigate DNA methylation response to Cd exposure. Larger studies are required.
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Background
Cadmium (Cd) is a naturally occurring toxic group IIb
transition metal that is ubiquitous in the earth’s crust.
Increased anthropogenic utilization of Cd in the last sev-
eral decades has led to increased human exposure at
high doses; exposure vectors are wide ranging, including
waste and emissions from mining, smelting, industrial
activities, sewage sludge, tobacco smoking and fruit and
vegetables contaminated by the use of phosphate fertil-
izers in agriculture [1]. Cd is a nephrotoxin, neurotoxi-
cant, osteotoxicant, and carcinogen [2]. Cellular effects
include apoptosis, DNA fragmentation and chromatin
structural changes. Cd exposure has also been impli-
cated in the etiology of fetal growth restriction [1, 3–5].
Zinc (Zn), and iron (Fe) are essential metals found in
wheat, seeds, beans, seafood, and red meats as well as
dietary supplements, and over-the-counter drugs [6]. Be-
cause Zn and Fe are co-factor for numerous enzymes in-
volved in nucleic acid synthesis and repair, they play a
significant role in growth, development, and cellular
functions [7, 8]. Animal and cross-sectional human data
suggest that at moderate levels, Zn and Fe may mitigate
Cd effects via trans-metallation processes; however em-
pirical data remain limited in human.
In vitro and in vivo studies demonstrated that expos-
ure to Cd modifies DNA methylation patterns [9–12],
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although specific targets remain largely unknown. In
humans, epigenetic targets for Cd exposure identified
from unbiased approaches lack specificity, and the mal-
leability of these epigenetic marks remains unknown.
Moreover, although the timing of exposure during the
life course is critical in determining severity of effects
following exposure, human data is primarily from cross-
sectional studies and reports in adults.
Parental allele-specific differentially methylated regions
(DMRs) of imprinted genes are established in the gam-
etes and in the early embryo, and are generally stable in
tissues from all germ layers. Perturbations in the estab-
lishment or maintenance of these DMRs during early
embryogenesis can result in systemic variability that may
be detected in nearly any tissue [13, 14]. Aberrant
methylation at some imprint regulatory regions has been
associated with lower birth weight [15].
In the present analysis, we examine the association be-
tween levels of Zn, Fe and Cd in pregnant women and
DNA methylation at imprinted regulatory DMRs in um-
bilical cord blood shown to be important in fetal growth
and development or associated with other toxic metals
including the H19 DMR regulating the IGF2/H19 do-
main, the MEG3 DMR regulating the MEG3 domain,
the SGCE/PEG10 DMR positioned between Epsilon Sar-
coglycan and Paternally Expressed Gene 10, the NNAT,
MEST and PEG. We hypothesized Cd exposure in utero
alters offspring DNA methylation levels in the DMRs
regulating genomically imprinted NNAT, MEST, PEG3,
PLAGL1, PEG10, IGF2, H19, and MEG3 DMRs and that
maternal Zn and Fe levels alter these associations.
Methods
Study participants
Study participants were pregnant women who were
enrolled as part of the Newborn Epigenetic STudy
(NEST), a prospective cohort study of women and
their offspring with the overarching goal of investigat-
ing the effects of in utero exposures on epigenetic
profiles and phenotypes in children. Between 2009
and 2011, pregnant women were recruited from five
prenatal clinics and obstetric care facilities at Duke
University and Durham Regional Hospitals. Details of
participant accrual have been previously described
[16, 17]. Eligibility criteria were age 18 years or older,
pregnant and intending to use one of two participat-
ing obstetric facilities in Durham County for delivery.
Excluded were women who planned to relinquish cus-
tody of the index child, move states in the subsequent
3 years, or had an established HIV infection. In the
18-month period between April, 2009 and 2011, 2,548
women were approached and 1,700 consented (66.7 %
response rate). The present analyses are limited to
the first 319 infant-mother pairs for whom maternal
Zn, Fe and Cd blood levels and infant DNA methyla-
tion were measured. Maternal race, smoking status, BMI
before pregnancy, parity, delivery route, and education
were comparable in the 319 infant-mother pairs included
in this study and the remainder of the cohort (p > 0.05).
The study protocol was approved by the Institutional
Review Boards of Duke and North Carolina State
Universities.
Data and specimen collection
Participants completed a self-administered question-
naire at the time of enrollment that included social and
demographic characteristics, reproductive history, life-
style factors, and anthropometric measurements. At
study enrollment, maternal peripheral blood samples were
collected; the mean gestational age at maternal blood draw
was 12 weeks. Infant cord blood specimens were collected
at birth. The leukocyte-containing buffy coat was isolated
following centrifugation at 3500 × g for 20 min at 4 °C.
Aliquots were prepared and stored at −80 °C.
DNA methylation analysis
Genomic DNA from buffy coat from umbilical cord
blood specimens was extracted using PureGene re-
agents (Qiagen; Valencia, CA) and treated with sodium
bisulfite using the Zymo EZ DNA Methylation Kit
(Zymo Research, Irvine, CA). Bisulfite treatment modi-
fies the DNA by converting unmethylated cytosines to
uracils but leaves methylated cytosines unchanged.
Pyrosequencing was performed using a Qiagen Pyro-
mark Q96 MD Pyrosequencer. Primers and PCR condi-
tions have been previously described [18, 19]. The
percent methylation for each CG dinucleotide was cal-
culated using PyroQ CpG Software (Qiagen). The per-
cent methylation was analyzed at multiple CpG sites
for nine imprinted gene DMRs, including the mater-
nally methylated NNAT, MEST, PEG3, PLAGL1, PEG10
DMRs and the paternally methylated IGF2, H19, and
MEG3 DMRs.
Measurement of Cd, Fe and Zn
Maternal Zn, Fe and Cd blood levels were measured in
whole blood as nanograms per gram (ng/g; 1000 ng/g =
1025 ng/μl) using well-established solution-based ICP-
MS methods [20–23]. Frozen maternal blood samples
were equilibrated at room temperature, homogenized
with a GlobalSpec laboratory slow shaker (GlobalSpec,
East Greenbrush, NY) and ~0.2 mL aliquots were pipet-
ted into a trace-metal-clean test tube and verified gravi-
metrically to ±0.001 mg using a calibrated mass balance.
Samples were then spiked with internal standards con-
sisting of known quantities (10 and 1 ng/g, respectively)
of indium (In) and bismuth (Bi) (obtained from SCP
Science), used to correct for instrumental drift. The
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solutions were then diluted using water purified to 18.2
MΩ/cm resistance (by a Milli-Q water purification sys-
tem, Millipore, Bedford, Mass., USA) and acidified
using ultra-pure 12.4 mol/L hydrochloric acid to result
in a final concentration of 2 % hydrochloric acid (by
volume). All standards, including aliquots of the certi-
fied NIST 955c, and procedural blanks were prepared
by the same process.
Zn, Fe and Cd concentrations were measured using a
Perkin Elmer DRC II (Dynamic Reaction Cell) axial
field ICP-MS at the University of Massachusetts-
Boston [20–23]. To clean sample lines and reduce
memory effects, sample lines were sequentially washed
with 18.2 MΩ cm resistance (by a Milli-Q water purifi-
cation system, Millipore, Bedford, Mass., USA) water
for 90 s and a 2 % nitric acid solution for 120 s between
analyses. Procedural blanks were analyzed within each
block of 10 samples, to monitor and correct for instru-
mental and procedural backgrounds. Calibration stan-
dards used to determine Zn and Cd in blood included
aliquots of 18.2 MΩ cm resistance H2O, NIST 955c
SRM, and NIST 955c SRM spiked with known quan-
tities of each metal in a linear range from 0.025 to
10 ng/g. Standards were prepared from 1000 mg/L sin-
gle element standards obtained from SCP Science,
USA. Method detection limits were calculated accord-
ing to the two-step approach using the t99SLLMV
method (USEPA, 1993) at 99 % CI (t = 3.71). The MDLs
for Zn and Cd yielded values of 278 and 83 pg/g parts
per trillion, respectively. Limits of detection (LOD) and
limits of quantification (LOQ) according to Long and
Winefordner (1983) were less than ~43 pg/g and
129 pg/g for Zn, respectively and less than ~17 pg/g
and 51 pg/g for Cd, respectively.
Measurement of folate
Maternal whole blood samples were sent to Craft Tech-
nologies (Wilson, NC, USA) for measurement of erythro-
cyte folate using a commercial kit, ID-Vit Folic acid
(Immundiagnostic-ALPCO; Salem, NH, Ref KIF005)
which uses the folate dependent strain Lactobacillus
rhamnosus (taxon id 47715) in a 96 well format.
Statistical analyses
Covariates considered for confounded were race/ethni-
city (White, African American, Hispanic, and other), and
parity (nulliparous and multiparous), physical activity
(≥3 days per week, yes/no), and maternal smoking (yes,
no, and quit during pregnancy). Maternal Zn, Fe and Cd
blood levels were natural log transformed to achieve a
normal distribution. Since at moderate levels, Zn and Fe
have been shown to interact with Cd and to mitigate cel-
lular, epigenetic and phenotypic effects in vivo and in
vitro [9, 11, 24, 25], we explored these potential effects
by categorizing Zn and Fe into high (top tertile) and low
(bottom two tertiles) levels. We then modeled blood Cd
on DMR methylation restricted to those with high and
low levels of Fe or Zn. Factors evaluated for confounding
were maternal age at delivery (less than 30 years, 30–39
years, and older than 40 years), the mother’s educational
achievement (high school graduate/less and college/be-
yond), household income (less than $24,999,
$25,000–$49,999, $50,000–$100,000, and more than
$100,000 per year), and BMI (kg/m2, normal <25, over-
weight 25–30, obese 30–35, and extremely obese >35) cal-
culated from self-reported maternal weight before
pregnancy at last menstrual period and measured height
at the study visit. Pre-pregnancy weight was verified with
the hospital medical charts. The accuracy of retrospect-
ively capturing weight was evaluated by abstracting weight
from medical records of 237 cohort members who visited
a Duke clinic within 6 months of their first prenatal visit
for the pregnancy that made them eligible for the study,
including a subset of 43 had visited within three months
of their first prenatal clinic visit. The correlation between
periconceptional self-reported and nurse-measured weight
was 0.95 in the 237 and 0.98 in the 43 participants, (p <
0.0001). Parturition data examined included gestational
age (preterm <258 days and term >259 days), delivery
route (vaginal and C-Section) and birth weight (in grams).
Given that maternal erythrocyte folate levels can affect
DNA methylation, we used measurements of folate using
methods previously described [15] based on a published
protocol [26]. Since childhood obesity may vary by ethni-
city/race, pre-pregnancy obesity, and sex, we also explored
the potential for effect modification of the associations be-
tween Cd and DNA methylations and obesity in early
childhood in African Americans, Hispanics and Whites.
Final models were adjusted for maternal race, maternal
smoking status, erythrocyte folate levels, parity, prenatal
physical activity, infant sex and maternal pre-pregnancy
BMI. All statistical analyses were conducted in Stata
Version 13.0 (Stata Corp, 2013) using the xtmixed
function, and findings were replicated in SAS. These
analyses were repeated using logistic regression models
where DNA methylation was dichotomized at the 4th
quartile, and weight at birth and age one year were catego-
rized at <2500, 2500–4000 and >4000 g and <85th, 85- <
95th, and >95th percentile, respectively, and findings were
comparable.
Results
Cd and socio-demographic characteristics
Maternal Cd levels did not vary by maternal age, pre-
pregnancy obesity, gestational age at delivery, or by sex
and birth weight of offspring. However, Cd levels were
somewhat higher among Hispanic and African American
women compared to White women (p = 0.03) (Table 1).
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Cd blood concentrations were also higher among smoking
mothers compared to nonsmoking mothers (p = 0.01), and
were higher in women who delivered vaginally, compared
to C-section deliveries (p = 0.02). These factors were
accounted for in multivariable analysis.
Maternal Cd exposure and newborn DMR methylation
We evaluated the association between maternal Cd levels
and DNA methylation at 9 differentially methylated re-
gions of genomically imprinted genes in the offspring. We
found a significant association between maternal Cd con-
centrations and altered methylation at the DMR regulating
PEG3 (β = 0.36, se = 0.17 p = 0.03). We also found associa-
tions of borderline significance between maternal Cd con-
centrations and altered methylation at the DMRs
regulating MEG3 (β = 0.44, se = 0.30, p = 0.14), and NNAT
(β = 0.54, se = 0.32, p = 0.09) (Table 2).
Associations may be specific to females at the PEG3
(β = 0.55, p = 0.05) but not in males (β = 0.09, p = 0.61);
whereas associations with the MEG3 (β =0.72, se = 0.41,
p = 0.08), and MEST (beta = 0.47, se = 0.29, p = 0.10)
DMRs may be specific to males and less evident in fe-
males. No evidence for sex-specific association at other
DMRs was found.
Despite higher levels of Cd in Hispanics, restricting
these analyses by self-reported ethnicity/race and further
adjusting for sex of offspring revealed other consistent
associations between Cd exposure and regulatory DMR
methylation (data not shown).
Maternal Fe and Zn abundance in associations between
Cd and DNA methylation at regulatory sequences of
genomically imprinted genes
We also explored the extent to which maternal Zn and
Fe altered the pattern of the associations observed be-
tween maternal Cd and offspring DNA methylation at
the MEG3, PLAGL1 and PEG3, by repeating the refined
models, restricted to women and children with high
concentrations of Zn or Fe (top tertile), and again
among those with low levels (bottom two tertiles)
(Fig. 1). We observed that higher Cd levels were associ-
ated with lower PLAGL1 DMR methylation levels in
women with lower Zn and Fe levels (Fig. 1a); the cross-
product term for the interaction between Zn and Cd
was p = 0.04, and that for Cd and Fe was (p = 0.37). We
also found that higher PEG3 DMR methylation levels
were associated with higher Cd concentrations, but this
association appeared limited to women with Zn levels in
the top tertile (p < 0.05) (Fig. 1b). The cross-product term
for the interaction between Cd and Zn was p = 0.01. This
positive association between elevated Cd levels and higher
Table 1 Distribution of maternal blood cadmium
concentrations (ng/g) (n = 319)
Characteristic Number Mean SD p-value
Child Gender 0.73
Male 164 4.43 (6.66)
Female 155 4.65 (5.53)
Gestation Time 0.12
Preterm (<37 weeks) 39 3.07 (4.70)
Normal(≥37 weeks) 280 4.74 (6.28)
Birth Weight 0.61
Low Birth Weight (<2500) 31 4.67 (5.93)
Normal Birth Weight(2500- < 4600) 281 4.58 (6.22)
High Birth Weight (>4600) 5 1.84 (1.40)
Maternal Age 0.35
Less than 30 187 4.93 (6.24)
30-39 125 3.96 (6.08)
40+ 7 4.28 (2.94)
Maternal Race 0.03
African American 111 4.71 (4.65)
White 95 3.13 (5.07)
Hispanic 101 5.44 (7.63)
Other 12 6.48 (9.51)
Maternal BMI 0.48
Less than 18.5 9 5.39 (7.46)
18.5 to less than 25 111 4.20 (5.83)
25 to less than 30 78 4.88 (5.90)
30 to less than 35 39 2.95 (3.55)
35+ 29 3.87 (4.25)
Maternal Smoking Status 0.01
Smoking Prior to Pregnancy 39 2.56 (3.13)
Smoking During Pregnancy 46 6.44 (4.79)
Never Smoke 225 4.42 (6.59)
Delivery Route 0.02
Vaginal 198 5.16 (6.72)
Cesarean section 120 3.50 (4.88)
Table 2 Regression coefficients, standard errors and p-values for
the association between maternal blood cadmium exposure
and offspring DNA methylation at DMRs imprinted genes
DMRs All Males Females
β, SE, P-value β, SE, P-value β, SE, p-value
IGF2/H19 −0.02, 0.18, 0.91 0.06, 0.25, 0.80 −0.20, 0.25, 0.42
MEG3 0.44, 0.30, 0.14 0.72, 0.41, 0.08 0.37, 0.42, 0.38
MEST 0.05, 0.22, 0.83 0.47, 0.29, 0.10 −0.34, 0.34, 0.31
NNAT 0.54, 0.32, 0.09 0.61, 0.45, 0.17 0.41, 0.48, 0.39
PEG3 0.36, 0.17, 0.03 0.09, 0.17, 0.61 0.55, 0.28, 0.05
SGCE/PEG10 0.01, 0.19, 0.98 −0.23, 0.26, 0.36 0.38, 0.28, 0.18
PLAGL1 −0.20, 0.34, 0.56 −0.42, 0.50, 0.40 −0.17, 0.48, 0.72
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PEG3 methylation was similar in women with high and
low Fe levels (Fig. 1b); the cross-product term for the
interaction between Fe and Cd was p = 0.45. We also
found no evidence that the association between Cd levels
and MEG3 DMR methylation varied by Fe and Zn nutri-
ent abundance (Fig. 1c).
Cd levels and birth weight
As Cd placental sequestration has been associated with
fetal growth restriction; consequently, we also evaluated
whether maternal Cd levels were associated with birth
weight (Table 3). We found that higher maternal Cd
concentrations in blood were associated with lower birth
weight (β = −51.89, se = 24.20, p = 0.03).
Discussion
While the known effects of Cd include replacement of
essential protein cofactors, protein disruption/misfold-
ing, generation of oxidative stress, and endocrine disrup-
tion, epigenetic mechanisms are emerging as a dynamic
Fig. 1 Regression coefficients for the associations between maternal
Cd and DNA methylation at newborns imprinted genes. a. Infants
born to women with high blood Cd concentrations but with lower
Zn and Fe levels, had lower DNA methylation at the PLAGL1 DMR. b.
Maternal higher Zn and Cd concentrations were associated with
higher methylation at the PEG3 DMR in newborns. c. No associations
were observed for MEG3
Table 3 Associations between maternal cadmium levels and
birth weight
Adjusted associations of Log Cd and
birth weight (n = 276)
β se p
Maternal
Log Cd −51.89 24.20 0.03
aRace/Ethnicity
NH Black −237.73 70.38 0.00
Hispanic −164.34 72.27 0.02
NH Other −222.72 134.09 0.10
Smoking
Smoking during pregnancy −173.52 106.27 0.10
Quit during pregnancy −12.21 85.77 0.89
Pre-Pregnancy BMI 13.68 3.99 0.00
Prenatal physical Activity 5.23 64.31 0.94
Periconceptional antibiotic use −94.61 60.38 0.12
Offspring
Female −107.72 52.19 0.04
Gestational Age at Delivery 26.48 2.19 0.00
Constant −3996.97 633.10 0.00
Characteristics mutually adjusted
aReferents are non-Hispanic whites
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mechanistic framework for how the environment inter-
acts with the genome to influence low birth weight and
cardio metabolic risk in later life. However, regions of
the human epigenome targeted by these ubiquitous toxic
metals are still unknown. Moreover, there is limited em-
pirical longitudinal human data on the role of essential
metals such as Zn and Fe, previously shown to be antag-
onists to Cd absorption in animal models [24, 25]. We
conducted an analysis to determine whether maternal
Cd concentrations, are associated with birth weight,
DNA methylation alterations at multiple DMRs regulat-
ing genomically imprinted genes after accounting for
maternal race/ethnicity, antibiotic use, physical activity,
parity, cigarette smoking and sex. We also evaluated the
extent to which the abundance of the essential minerals,
Zn and Fe modify this association.
Our key finding was that elevated Cd levels were sig-
nificantly associated with higher DNA methylation at
the DMR regulating PEG3; these associations varied by
Zn or Fe circulating levels. We also found that higher
maternal Cd levels were associated with lower birth
weight. Our data support that early Cd exposure is
gene-specific as DNA methylation of several other
DMRs evaluated in newborns were not associated with
prenatal levels of Cd. DNA methylation at these regula-
tory DMRs are established in gametogenesis and
embryogenesis and may be vulnerable to availability/
abundance of circulating essential metals, including Fe
and Zn. DNA methylation marks here examined have
previously been associated with fetal development. If
these findings are replicated in a larger study and from a
wider scope of regulatory regions, our findings suggest
that nutritional manipulation during vulnerable periods
in life could alter disease course, in Cd-exposed popula-
tions. Moreover, if these epigenetic marks are confirmed
to be stable in humans, these regions could be developed
as markers of periconceptional Cd exposure, for poten-
tial use in risk assessment.
Our data suggest that Cd concentrations during early
pregnancy are associated with lower levels of new-
born’s DNA methylation at the DMR regulating PEG3,
and less consistently at IGF2/H19 and MEG3 and none
with PLAGL1 imprinted domains. PEG3 is a paternally
expressed imprinted gene, maps to chromosome 19q13.43
and encodes a zinc finger protein with a tumor suppressor
function that plays a role in facilitating p53/c-myc-me-
diated apoptosis. PEG3 also plays a critical role in brain
development where it is mainly expressed in the mes-
encephalon and the pituitary gland [27]. Shifts in DNA
methylation at the PEG3 DMR have been shown to
alter social and maternal nurturing behaviors in mice
[27, 28] and to be associated with human cancer [19],
presumably caused by a decrease in PEG3 transcription
[29, 30]. In support, a long term follow-up study, lower
PEG3 DMR methylation was recently associated with
exposure to lead, a +2 toxic metal that tends to co-
occur with Cd (Li et al., in press). Lower DNA methyla-
tion levels at the same PEG3 DMR in males and IGF2/
H19 DMR in females have been associated with expos-
ure to another environmentally abundant neurotoxin,
lead, during the neonatal period (Li et al., in press).
While we know of no other study that has examined
Cd exposure in relation to epigenetic dysregulation spe-
cifically targeting genomically imprinted genes, our find-
ings that Cd exposure in utero is associated with DNA
methylation differences is consistent with in vitro and
ex-vivo systems studies showing that Cd is an effective
inhibitor of DNA methyltransferase. Specifically, Cd ini-
tially induces DNA hypomethylation, although pro-
longed Cd exposure results in DNA hypermethylation
and enhanced DNA methyltransferase activity [9]. In
humans, gene-specific studies based on known gene
function have shown DNA methylation alterations in re-
sponse to Cd exposure [31, 32]; however, few have been
conducted at birth to reflect the periconceptional envir-
onment [12]. Using the unbiased Illumina Human-
Methylation450 BeadChip, maternal cigarette smoking, a
common source of fetal Cd exposure, has been associ-
ated with altered DNA methylation at multiple CpG sites
including 11 imprinted genes such as AHRR, GFI1, IGF2
and CYP1A1 in cord blood leukocyte DNA [33, 34]. In
studies with small sample sizes [12, 35], in utero Cd ex-
posure specifically was associated with CpG methylation
differences in umbilical cord blood leukocyte DNA at
multiple CpG sites mapping to genes involved in xeno-
biotic metabolism and inflammation [12], some of
which may be sex-specific [36, 37]. Female-specific ef-
fects of Cd exposure have previously been reported in
relation to birth weight, hypothesized to be due to
lower iron in females that is associated with increased
Cd intestinal absorption [38]. Therefore, while findings
from these gene-specific and genome-scale studies do
not include regions regulating PLAGL1, MEG3 and
PEG3 examined here, together they support that in
utero Cd exposure alters the epigenome.
Our findings that the association among maternal Cd
and CpG methylation vary by Zn and Fe concentrations
are consistent with the toxicity of these essential metals
when present in excess, and reduced intestinal absorp-
tion reported in animal models. Both Zn and Fe have
been shown to mitigate cellular, epigenetic and pheno-
typic effects in vivo and in vitro [9, 11, 23, 24, 39].
Mechanisms by which Fe or Zn may decrease harmful
effects of Cd exposure remain unknown, although are an
active topic of investigation. Studies suggest that mar-
ginal intakes of Zn, Fe, and Ca cause the accumulation
of Cd in the duodenum, which results in a greater rate
of Cd absorption and a greater accumulation in the
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internal organs [24, 25], which may influence fetal devel-
opment and epigenetic dysregulation. However, these as-
sociations may also depend on other essential elements
as well as age and sex. Cd may compete with essential
metals for binding to transporter molecules. Indeed, Fe
deficiency has been shown to upregulate Fe trans-
porters and subsequently, increased Cd in duodenal
mucosa [40, 41]. Deficiencies or excesses of these es-
sential metals can contribute to epigenetic alterations
and/or other mechanisms to influence phenotypes such
as birth weight and childhood obesity [42], associations
that may vary by race/ethnicity as our present results
suggest. Zn and Fe are essential co-factor for many en-
zymes that epigenetically modify DNA and histones,
and maternal Zn excess or deficiencies may program
offspring growth trajectories by altering epigenetic
modifications of DNA and histones [39, 43, 44] at labile
loci. Together, our findings corroborate animal and in
vitro data [9, 24, 25].
A strength of our study is its longitudinal design in
early life, as few studies examine Cd exposure before
birth. Because Cd and Zn measurements were made in
erythrocytes at gestational age <12 weeks, and many
heavy metals bind to erythrocytes (a 120 day lifespan),
metal concentrations examined here likely represent
those of the periconceptional environment. As nutrient
concentrations vary by ethnicity (NHANES), another
strength is the multiethnic composition of the cohort,
enabling examination of the effects of Cd and Zn on
the four major ethnic group in the US: Whites, Blacks,
Hispanics and Asians. However, given race/ethnic het-
erogeneity, we cannot exclude the possibility that our
inability to find statistically significant associations be-
tween altered methylation at other DMRs in response
to Cd exposure could be due, in part, to our limited
statistical power in race-specific analyses. While statis-
tical power was adequate for overall analyses, we are
underpowered for examining higher-order interaction
by race. Also, we examined only eight DMRs of more
than 65 genes currently known to be imprinted in
humans, these 65 genes themselves represent only 1-
5 % of the human genome [45]. Analysis of the methy-
lation status of a wider spectrum of the epigenome will
be required to clarify the spectrum of genes and path-
ways that contribute to the association between mater-
nal Cd and DNA methylation alterations in newborns.
Despite these limitations, our data suggest that mater-
nal exposure to Cd is associated with aberrant DNA
methylation at multiple regions previously associated
with preterm birth [46], fetal growth restriction and neu-
rodevelopmental disorders, as previously reported in other
geographic regions [36, 47]. With replication, PLAGL1
and PEG3 could be considered among epigenetic regions
perturbed by Cd exposure early in utero.
Conclusions
Although epigenetic mechanisms have been proposed to
link early Cd exposure to human health, human data are
still limited, as epigenetic targets that may influence hu-
man health are still unknown. We present data consist-
ent with the hypothesis that maternal Cd exposure in
early pregnancy alters DNA methylation at multiple
DMRs in offspring with sex and possibly race/ethnic-
specific effects, and that Zn may mitigate these effects.
We also contribute data suggesting that early Cd expos-
ure is associated with lower birth weight. As our data
were too limited for mediation analyses, larger studies
are required to confirm these findings and to determine
the role of other imprinted and non-imprinted genes in
the associations between Cd, Fe and Zn exposure in epi-
genetic alterations with known methylation profiles, and
low birth weight, a consistent risk factor for childhood
obesity and other chronic diseases. Such efforts would
contribute data to nutritional policy related to these ubi-
quitous toxic metals.
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